Freenome
FRNM
16.03
-0.33
-2.02%
Freenome
US · FRNM
#2882 by market cap
Listed 2024
16.03
-0.33
-2.02%
Live - 5344 symbols - heartbeat 3s ago
· 2026-10-08 07:56
Pre-market
15.93
-0.63%
After-hours
16.03
0.00%
- Market cap
- 1.72B
- P/E (TTM)i
- -6.71
- P/Bi
- -1.24
- EPSi
- -2.39
- Div yieldi
- 0.00%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on FRNM?
Anonymous reader poll. Unscientific, not investment advice.
About Freenome
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
- CEO
- Dr. Aaron Elliott, PhD
- Fiscal year end
- 12-31
- Website
- freenome.com
Company profile
- Exchange
- US
- Symbol
- FRNM
- Market-cap rank
- #2882
- Listing date
- 2024-06-12
- Market cap
- 1.72B
- Float cap
- 798.04M
- Shares out
- 107.45M
- Float shares
- 49.78M
Sectors & themes
Quote time 2026-10-08 07:56:09 · For reference only, not investment advice and not tailored to your situation.